Portal Instruments is pleased to be showcasing its latest drug delivery platform at the LSI conference in California next week. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact.
Portal Instruments will be showcasing its newest drug delivery platform at the prestigious Life Science Intelligence (LSI) conference in California next week. The company plans to showcase its latest injector platform, representing a significant advancement in reusable injectors. CEO Patrick Anquetil will be available for personalized demonstrations and in-depth discussions about the technology's benefits and potential impact on the industry. This appearance at LSI marks an important milestone for Portal as it continues to expand its market presence and forge strategic partnerships within the healthcare ecosystem. Industry experts and potential investors are encouraged to schedule meetings with the Portal team to explore collaboration opportunities and witness firsthand how their innovations are addressing critical challenges in medical delivery systems.
October 1, 2023 - In a special feature by Drug Development and Delivery, Dr. Anquetil, PHD, MBA, CEO and Founder of Portal Instruments, explains how PRIME not only prioritizes patient comfort and compliance but also aligns with environmental sustainability.
June 30, 2022 - Logan Merrill has taken testosterone injections for 6 years. In this piece, Logan talks about his transition and the process of taking his injections. This blog was written by Logan Merrill for Portal Instruments. All opinions and experiences shared are entirely his own.
November 2024, Cambridge, MA – Seasoned drug delivery executive, Steven Kaufman, to join Portal Instruments as their Chief Commercial Officer. Prior to joining Portal Instruments in November 2024, Steven held executive positions at Stevanato Group, Bespak and SHL Medical.
Please fill out the details below and we will get back to you shortly.